NextCure, Inc. (NXTC) stock
NXTCNasdaqPharmaceutical PreparationsFiscal year ends December 31
$6.88+0.18 (+2.76%)
Close on Nov 18, 2026Market cap $31.52MP/E –Yield 0.00%
NextCure shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
NextCure's shares outstanding was 5M at Jun 30, 2026. For fiscal 2025 it was 3M, up 22.0% from the year before. The highest annual figure on record is 3M in fiscal 2025.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 3M | +22.0% |
| FY2024 | Dec 31, 2024 | 2M | +0.5% |
| FY2023 | Dec 31, 2023 | 2M | +0.3% |
| FY2022 | Dec 31, 2022 | 2M | +0.5% |
| FY2021 | Dec 31, 2021 | 2M | +0.3% |
| FY2020 | Dec 31, 2020 | 2M | +75.4% |
| FY2019 | Dec 31, 2019 | 1M | +1045.8% |
| FY2018 | Dec 31, 2018 | 0M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 5M | +123.6% |
| Q1 FY2026 | Mar 31, 2026 | 5M | +124.5% |
| Q4 FY2025 | Dec 31, 2025 | 4M | +70.6% |
| Q3 FY2025 | Sep 30, 2025 | 3M | +14.8% |
| Q2 FY2025 | Jun 30, 2025 | 2M | +1.9% |
| Q1 FY2025 | Mar 31, 2025 | 2M | +0.4% |
| Q4 FY2024 | Dec 31, 2024 | 2M | +0.4% |
| Q3 FY2024 | Sep 30, 2024 | 2M | +0.5% |
| Q2 FY2024 | Jun 30, 2024 | 2M | +0.5% |
| Q1 FY2024 | Mar 31, 2024 | 2M | +0.5% |
| Q4 FY2023 | Dec 31, 2023 | 2M | +0.5% |
| Q3 FY2023 | Sep 30, 2023 | 2M | +0.3% |
| Q2 FY2023 | Jun 30, 2023 | 2M | +0.3% |
| Q1 FY2023 | Mar 31, 2023 | 2M | +0.2% |
| Q4 FY2022 | Dec 31, 2022 | 2M | +0.5% |
| Q3 FY2022 | Sep 30, 2022 | 2M | +0.5% |
| Q2 FY2022 | Jun 30, 2022 | 2M | +0.5% |
| Q1 FY2022 | Mar 31, 2022 | 2M | +0.4% |
| Q4 FY2021 | Dec 31, 2021 | 2M | +0.3% |
| Q3 FY2021 | Sep 30, 2021 | 2M | +0.2% |
| Q2 FY2021 | Jun 30, 2021 | 2M | +0.3% |
| Q1 FY2021 | Mar 31, 2021 | 2M | -6.0% |
| Q4 FY2020 | Dec 31, 2020 | 2M | +10.4% |
| Q3 FY2020 | Sep 30, 2020 | 2M | +21.3% |
| Q2 FY2020 | Jun 30, 2020 | 2M | +103.9% |
| Q1 FY2020 | Mar 31, 2020 | 2M | +2027.6% |
| Q4 FY2019 | Dec 31, 2019 | 2M | +1719.1% |
| Q3 FY2019 | Sep 30, 2019 | 2M | +1559.0% |
| Q2 FY2019 | Jun 30, 2019 | 1M | +885.9% |
| Q1 FY2019 | Mar 31, 2019 | 0M | +0.7% |
| Q4 FY2018 | Dec 31, 2018 | 0M | – |
| Q3 FY2018 | Sep 30, 2018 | 0M | – |
| Q2 FY2018 | Jun 30, 2018 | 0M | – |
| Q1 FY2018 | Mar 31, 2018 | 0M | – |
See a number that looks wrong?